The Emmes Company

VaxTrials is a clinical research organization focused on managing and monitoring vaccination clinical trials. The company offers a variety of services, including project feasibility assessment, site management, clinical supplies management, pharmacovigilance, and safety and medical monitoring. By providing these comprehensive solutions, VaxTrials aims to facilitate the efficient conduct of vaccine trials, ultimately contributing to the eradication of preventable diseases.

Essex Management specializes in biomedical informatics and health information technology services. The firm offers a range of consulting services tailored to federal government agencies, research institutions, and private sector clients. Their expertise encompasses computational biology, bioinformatics, systems design and engineering, and comprehensive program and project management. By focusing on data management, genetic sequencing, and the development of analytics and algorithms, Essex Management aims to enhance clients' investments in technology and informatics. Additionally, the company provides services such as application engineering, machine learning, integrated process automation, and stakeholder management, all designed to improve outcomes for patients and clinicians.

Clinical Edge offers Visual Acuity Examiner and Visual Acuity Room Certification to ensure quality and consistency amongst clinical sites participating in the conduct of Ophthalmology drug, biologic, and device trials.

Casimir is a contract research organization that emphasizes the patient's perspective in its clinical studies, particularly in the context of rare diseases. The company utilizes innovative approaches, such as virtual trials and remote assessments, to enhance understanding of disease progression and treatment effects. By focusing on qualitative research, Casimir aims to capture the real-world impact of treatment interventions on patient quality of life through intelligent outcome measures. This commitment to prioritizing the patient experience allows Casimir to contribute valuable insights into the effectiveness of medical treatments.

Institut Dr. Schauerte (IDS) is a clinical research organization based in Munich that provides a range of services focused on late-phase, non-interventional studies, including post-market clinical follow-up (PMCF) and registry studies. The organization is dedicated to complex study designs tailored to meet the unique requirements of investigator-initiated trials (IITs) and emphasizes the importance of real-world evidence in the healthcare and biopharmaceutical sectors. By offering secure and user-friendly e-clinical solutions, IDS supports study centers in advancing public health and fostering innovation within the pharmaceutical industry.

Orphan Reach is a global clinical research organization (CRO) specializing in services for rare diseases. The company has established a strong reputation for its comprehensive clinical development capabilities, guiding clients from early patient trials to marketing authorization. Orphan Reach offers a wide range of services, including project management, clinical monitoring, safety and pharmacovigilance, quality assurance, data management, and biostatistics, all tailored to meet the specific needs of its clients. The organization focuses on addressing the unique challenges associated with rare diseases, particularly those involving small patient populations. By providing bespoke solutions that adapt to the requirements of orphan drug developers, Orphan Reach enhances the drug development process, ensuring that researchers can effectively navigate the complexities of bringing innovative treatments to market.

Neox s.r.o. is a contract research organization based in Prague, Czechia, that provides comprehensive clinical research support services. Established in 1995, Neox specializes in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies across Europe and the United States. The organization offers a wide range of services covering all phases of drug development, including medical writing, site contracting, clinical monitoring, project management, pharmacovigilance, and regulatory support. Neox also caters to medical device development and real-world evidence/data management. With years of experience and an understanding of local requirements, the company emphasizes optimal trial settings to enhance patient enrollment. Neox operates in multiple countries, including Austria, Belgium, Germany, and the United Kingdom, ensuring a broad geographical reach for its clinical research activities. As of December 2020, Neox serves as a subsidiary of The Emmes Company, LLC.